Advisory Research’s Arcellx ACLX Stock Holding History

Advisory Research’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,530	Closed	-$529K	–	159
2023 Q4	$529K	Buy	+9,530	New	+$430K	0.08%	232

Other funds holding ACLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Advisory Research's ACLX Position: Q1 2024 in Review

Advisory Research sold out of Arcellx (ACLX) in Q1 2024, closing a stake of 9,530 shares — an estimated $529K sold.

Advisory Research first reported a position in ACLX in Q4 2023 and held it in 1 quarter. The position peaked at $529K in Q4 2023. 183 funds tracked by Wall St. Rank hold ACLX as of Q1 2024.

Advisory Research reported no remaining Arcellx position as of Q1 2024 after selling out during the quarter.
Advisory Research sold 9,530 Arcellx shares in Q1 2024, an estimated $529K.
Advisory Research first reported a position in Arcellx in Q4 2023 and held it in 1 quarter.
Advisory Research's Arcellx position peaked at $529K in Q4 2023.
183 funds tracked by Wall St. Rank held Arcellx as of Q1 2024.

Based on Advisory Research's 13F filing for Q1 2024, filed 14 May 2024.